BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 4, 2003
View Archived Issues
PH-027, a novel antimicrobial agent, has potent activity against anaerobic bacteria
Read More
NO blocks platelet-leukocyte aggregate formation in acute respiratory distress syndrome
Read More
Cathepsin B as a therapeutic target in cancer and arthritis
Read More
Duloxetine for painful diabetic neuropathy
Read More
Rapid absorption and onset of action for insulin glulisine in dogs and humans
Read More
Novel cathepsin K inhibitors in GSK development pipeline
Read More
ACAT inhibitors prepared and tested at Takeda
Read More
Yamanouchi scientists describe new PARP inhibitors and their use
Read More
Shionogi patent describes new antidiabetic agents
Read More
Novel group II mGluR antagonists under study at Taisho
Read More
Beneficial effects described for inhaled insulin in type 2 diabetes
Read More
Potential role for ruboxistaurin in diabetic microvascular complications
Read More
Acetyl-CoA carboxylase inhibitors, their preparation and use claimed by Ajinomoto
Read More
Neuroprotective effects of AT-1015 in rats with diabetic neuropathy
Read More
Mechanism of protective effects of pyridoxamine against diabetic nephropathy
Read More
Second approvable letter issued for duloxetine
Read More
TLK-286 awarded fast track status for advanced ovarian cancer
Read More
Avandia label expanded in Europe
Read More
New PPARalpha activator improves insulin sensitivity and lipid profiles in primates
Read More
HIM2 effects on glucose production and disposal in nondiabetic subjects
Read More
Rifaximin efficacy confirmed in phase III travelers' diarrhea trial
Read More
Satraplatin phase III trial cleared to begin
Read More
Paxil CR approved for premenstrual dysphoric disorder
Read More
BMS returns quinolone antibiotic to Toyama
Read More
Bifeprunox to enter phase III development for schizophrenia
Read More
FluMist available for 2003-2004 influenza season
Read More